<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font6" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font7" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font8" size="8" family="GillSans" color="#000000"/>
<text top="41" left="55" width="199" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Osteopathic Medicine and Primary Care 2007, 1 :7<i>Osteopathic Medicine and Primary Care</i></text>
<text top="41" left="411" width="143" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.om-pc.com/content/1/1/7</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="105" segment_no="11" tag_type="text">Page 5 of 8<b>1</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="106" segment_no="12" tag_type="text">(page number not for citation purposes)</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="32" segment_no="5" tag_type="text">pain with OMT. A comprehensive series of subgroup and</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="33" segment_no="5" tag_type="text">sensitivity analyses were also performed as part of the</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="34" segment_no="5" tag_type="text">meta-analysis. These demonstrated that: (1) OMT pro-<i>(page number not for citation purposes)</i></text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="35" segment_no="5" tag_type="text">vided greater pain reduction than active or placebo con-</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="36" segment_no="5" tag_type="text">trol treatments (ES, -0.26; 95% CI, -0.48 – -0.05; P = .02);</text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="37" segment_no="5" tag_type="text">(2) the effects of OMT were comparable regardless of</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="38" segment_no="5" tag_type="text">whether treatment was provided by fully-licensed osteo-</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="39" segment_no="5" tag_type="text">pathic physicians in the United States (ES, -0.31; 95% CI,</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="40" segment_no="5" tag_type="text">-0.52 – -0.10; P = .004) or by osteopaths in the United</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="41" segment_no="5" tag_type="text">Kingdom (ES, -0.29; 95% CI, -0.58 – -0.00; P = .05); and</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="42" segment_no="5" tag_type="text">(3) the effects of OMT increased over time (ES, -0.28; 95%</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="43" segment_no="5" tag_type="text">CI, -0.51 – -0.06; P = .02 for short-term treatment [less</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="44" segment_no="5" tag_type="text">than one month]; ES, -0.33; 95% CI, -0.51 – -0.15; P &lt;</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="45" segment_no="5" tag_type="text">.001 for intermediate-term treatment [one month to less</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="46" segment_no="5" tag_type="text">than three months]; ES, -0.40; 95% CI, -0.74 – -0.05; P =</text>
<text top="463" left="55" width="229" height="9" font="font4" id="p1_t20" reading_order_no="47" segment_no="5" tag_type="text">.03 for long-term treatment [three months or longer]).</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="48" segment_no="7" tag_type="text">Several important implications derive from these find-</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="49" segment_no="7" tag_type="text">ings. The pain-reducing effects of OMT are significantly</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="50" segment_no="7" tag_type="text">greater than those of a placebo or sham treatment. In fact,</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="51" segment_no="7" tag_type="text">by comparison with published data, the pain reduction</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="52" segment_no="7" tag_type="text">afforded by OMT is comparable to that of non-steroidal</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="53" segment_no="7" tag_type="text">anti-inflammatory drugs, including cyclo-oxygenase-2</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="54" segment_no="7" tag_type="text">inhibitors [14], and may potentially last longer than these</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="55" segment_no="7" tag_type="text">drugs [15]. With the adverse events known to be associ-</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="56" segment_no="7" tag_type="text">ated with non-steroidal anti-inflammatory drugs, and</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="57" segment_no="7" tag_type="text">more intense scrutiny of the safety profile of cyclo-oxyge-<a href="">[14], and m</a>ay potentially last longer than these</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="58" segment_no="7" tag_type="text">nase-2 inhibitors, OMT may offer an attractive alternative<a href="">ugs [15]. With the advers</a>e events known to be associ-</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="59" segment_no="7" tag_type="text">to such drugs in many patients with low back pain, partic-</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="60" segment_no="7" tag_type="text">ularly those patients requiring ongoing treatment of</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="61" segment_no="7" tag_type="text">chronic pain. Finally, for planning purposes, it is impor-</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="62" segment_no="7" tag_type="text">tant to recognize that previous osteopathic clinical trials</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="63" segment_no="7" tag_type="text">have generally been inadequately powered to detect out-</text>
<text top="674" left="55" width="184" height="9" font="font4" id="p1_t37" reading_order_no="64" segment_no="7" tag_type="text">comes at the threshold of clinical relevance.</text>
<text top="698" left="55" width="88" height="9" font="font5" id="p1_t38" reading_order_no="65" segment_no="9" tag_type="title">Osteopathic enigmas</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="66" segment_no="10" tag_type="text">Webster's Thesaurus lists the following synonyms for the</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="67" segment_no="10" tag_type="text">term "enigma": puzzle, riddle, question, perplexity,</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t41" reading_order_no="68" segment_no="6" tag_type="text">conundrum, mystery, secret, and hidden meaning. A clus-<i><b>Osteopathic enigmas</b></i></text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t42" reading_order_no="69" segment_no="6" tag_type="text">ter of vaginal adenocarcinoma cases among young</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t43" reading_order_no="70" segment_no="6" tag_type="text">women at a Boston hospital between 1966 and 1969 rep-</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t44" reading_order_no="71" segment_no="6" tag_type="text">resented an enigma, as this type of cancer was rare and</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t45" reading_order_no="72" segment_no="6" tag_type="text">unusual in young women [16]. No obvious causal factors</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t46" reading_order_no="73" segment_no="6" tag_type="text">were originally identified. The resolution of this enigma</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t47" reading_order_no="74" segment_no="6" tag_type="text">was facilitated by the deceptively simple consideration of</text>
<text top="369" left="313" width="241" height="9" font="font6" id="p1_t48" reading_order_no="75" segment_no="6" tag_type="text">in-utero exposures among the cancer cases. A case-control<a href="">n [16]</a>. No obvious causal factors</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="76" segment_no="6" tag_type="text">study then implicated maternal diethylstilbestrol (DES) as</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="77" segment_no="6" tag_type="text">the causal factor in subsequent development of vaginal</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="78" segment_no="6" tag_type="text">adenocarcinoma in the exposed daughters [16]. Some-<i>in-utero </i></text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="79" segment_no="6" tag_type="text">times the resolution of an enigma is much more complex,</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t53" reading_order_no="80" segment_no="6" tag_type="text">as evidenced by the "Enigma machine" used by the Ger-</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t54" reading_order_no="81" segment_no="6" tag_type="text">man military to encode secrets during World War II. The</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t55" reading_order_no="82" segment_no="6" tag_type="text">basis for this enigma was the sheer number of possible<a href=""> [16]</a>. Some-</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="83" segment_no="6" tag_type="text">internal connections within the machine, far surpassing</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="84" segment_no="6" tag_type="text">the capability of any individual or small group to decode</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="85" segment_no="6" tag_type="text">the information. This enigma was overcome only by the</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="86" segment_no="6" tag_type="text">concerted efforts of many cryptanalysts working synergis-</text>
<text top="510" left="313" width="188" height="9" font="font4" id="p1_t60" reading_order_no="87" segment_no="6" tag_type="text">tically with Allied forces throughout the war.</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="88" segment_no="8" tag_type="text">Osteopathic medicine has its enigmas as well. An enigma</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="89" segment_no="8" tag_type="text">integral to osteopathic principles involves the complex</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="90" segment_no="8" tag_type="text">inter-relationships among the spinal cord, autonomic</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="91" segment_no="8" tag_type="text">nervous system, and viscera. Louisa Burns performed ani-</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="92" segment_no="8" tag_type="text">mal research in this area in the early 1900s and was the</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="93" segment_no="8" tag_type="text">first osteopathic investigator to establish and carry on a</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="94" segment_no="8" tag_type="text">long-term research program [17]. J. Stedman Denslow</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="95" segment_no="8" tag_type="text">moved the field of osteopathic research forward in the</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="96" segment_no="8" tag_type="text">1940s at the Kirksville College of Osteopathy and Surgery,</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="97" segment_no="8" tag_type="text">where he also recruited many able investigators, including</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="98" segment_no="8" tag_type="text">Irvin Korr [17]. However, the clinical applications of such<a href="">17]</a>. J. Stedman Denslow</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="99" segment_no="8" tag_type="text">research have materialized slowly over time and much</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="100" segment_no="8" tag_type="text">remains to be explored at present. The preliminary results</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="101" segment_no="8" tag_type="text">of case-control studies at the Osteopathic Research Center</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="102" segment_no="8" tag_type="text">have shown significant associations between osteopathic<a href="">17]</a>. However, the clinical applications of such</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="103" segment_no="8" tag_type="text">palpatory findings and chronic diseases, including type 2</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="104" segment_no="8" tag_type="text">diabetes mellitus [18] and hypertension [19]. As with the</text>
<text top="87" left="55" width="478" height="7" font="font7" id="p1_t78" reading_order_no="2" segment_no="2" tag_type="title">Table 1: Recommendations of the Agency for Health Care Policy and Research on spinal manipulation for low back problems in</text>
<text top="96" left="55" width="26" height="7" font="font7" id="p1_t79" reading_order_no="3" segment_no="2" tag_type="title">adults*</text>
<text top="114" left="59" width="69" height="7" font="font7" id="p1_t80" reading_order_no="4" segment_no="3" tag_type="table">Recommendation</text>
<text top="114" left="347" width="25" height="7" font="font7" id="p1_t81" reading_order_no="5" segment_no="3" tag_type="table">Rating<a href="">18</a>] and hypertensi<a href="">on [19</a>]. As with the</text>
<text top="114" left="380" width="66" height="7" font="font7" id="p1_t82" reading_order_no="6" segment_no="3" tag_type="table">Level of evidence<b>Table 1: Recommendations of the Agency for Health Care Policy and Research on spinal manipulation for low back problems in </b></text>
<text top="137" left="59" width="265" height="7" font="font8" id="p1_t83" reading_order_no="7" segment_no="3" tag_type="table">Manipulation can be helpful for patients with acute low back problems without<b>adults*</b></text>
<text top="146" left="59" width="206" height="7" font="font8" id="p1_t84" reading_order_no="8" segment_no="3" tag_type="table">radiculopathy when used within the first month of symptoms.<b>Recommendation</b></text>
<text top="137" left="358" width="5" height="7" font="font8" id="p1_t85" reading_order_no="9" segment_no="3" tag_type="table">B<b>Rating</b></text>
<text top="137" left="380" width="117" height="7" font="font8" id="p1_t86" reading_order_no="10" segment_no="3" tag_type="table">Moderate research-based evidence<b>Level of evidence</b></text>
<text top="156" left="59" width="268" height="7" font="font8" id="p1_t87" reading_order_no="11" segment_no="3" tag_type="table">When findings suggest progressive or severe neurologic deficits, an appropriate</text>
<text top="165" left="59" width="278" height="7" font="font8" id="p1_t88" reading_order_no="12" segment_no="3" tag_type="table">diagnostic assessment to rule out serious neurologic conditions is indicated before</text>
<text top="175" left="59" width="105" height="7" font="font8" id="p1_t89" reading_order_no="13" segment_no="3" tag_type="table">beginning manipulation therapy.</text>
<text top="156" left="357" width="6" height="7" font="font8" id="p1_t90" reading_order_no="14" segment_no="3" tag_type="table">D</text>
<text top="156" left="380" width="161" height="7" font="font8" id="p1_t91" reading_order_no="15" segment_no="3" tag_type="table">Panel interpretation of information that did not</text>
<text top="165" left="380" width="168" height="7" font="font8" id="p1_t92" reading_order_no="16" segment_no="3" tag_type="table">meet inclusion criteria as research-based evidence</text>
<text top="185" left="59" width="254" height="7" font="font8" id="p1_t93" reading_order_no="17" segment_no="3" tag_type="table">There is insufficient evidence to recommend manipulation for patients with</text>
<text top="194" left="59" width="47" height="7" font="font8" id="p1_t94" reading_order_no="18" segment_no="3" tag_type="table">radiculopathy.</text>
<text top="185" left="357" width="6" height="7" font="font8" id="p1_t95" reading_order_no="19" segment_no="3" tag_type="table">C</text>
<text top="185" left="380" width="109" height="7" font="font8" id="p1_t96" reading_order_no="20" segment_no="3" tag_type="table">Limited research-based evidence</text>
<text top="204" left="59" width="280" height="7" font="font8" id="p1_t97" reading_order_no="21" segment_no="3" tag_type="table">A trial of manipulation in patients without radiculopathy with symptoms longer than</text>
<text top="214" left="59" width="175" height="7" font="font8" id="p1_t98" reading_order_no="22" segment_no="3" tag_type="table">one month is probably safe, but efficacy is unproven.</text>
<text top="204" left="357" width="6" height="7" font="font8" id="p1_t99" reading_order_no="23" segment_no="3" tag_type="table">C</text>
<text top="204" left="380" width="109" height="7" font="font8" id="p1_t100" reading_order_no="24" segment_no="3" tag_type="table">Limited research-based evidence</text>
<text top="224" left="59" width="280" height="7" font="font8" id="p1_t101" reading_order_no="25" segment_no="3" tag_type="table">If manipulation has not resulted in symptomatic improvement that allows increased</text>
<text top="233" left="59" width="280" height="7" font="font8" id="p1_t102" reading_order_no="26" segment_no="3" tag_type="table">function after one month of treatment, manipulation therapy should be stopped and</text>
<text top="242" left="59" width="81" height="7" font="font8" id="p1_t103" reading_order_no="27" segment_no="3" tag_type="table">the patient re-evaluated.</text>
<text top="224" left="357" width="6" height="7" font="font8" id="p1_t104" reading_order_no="28" segment_no="3" tag_type="table">D</text>
<text top="224" left="380" width="161" height="7" font="font8" id="p1_t105" reading_order_no="29" segment_no="3" tag_type="table">Panel interpretation of information that did not</text>
<text top="233" left="380" width="168" height="7" font="font8" id="p1_t106" reading_order_no="30" segment_no="3" tag_type="table">meet inclusion criteria as research-based evidence</text>
<text top="265" left="59" width="75" height="7" font="font8" id="p1_t107" reading_order_no="31" segment_no="4" tag_type="text">*Based on reference 6</text>
</page>
</pdf2xml>
